These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9919890)

  • 1. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
    Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
    Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Wardle HM; Law D; Moore CB; Mason C; Denning DW
    Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal activities of D0870 against fluconazole-resistant Candida albicans].
    Kojima M; Yamada H; Nakamura S; Kikuchi M; Nakanishii T; Takahashi Y; Mochizuki H; Mikami Y
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):209-15. PubMed ID: 10536307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
    AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
    Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1382-6. PubMed ID: 8726005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.
    Lee JK; Peters D; Obias AA; Noskin GA; Peterson LR
    Int J Antimicrob Agents; 2000 Nov; 16(3):205-9. PubMed ID: 11091037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of D0870 treatment of experimental Candida vaginitis.
    Fidel PL; Cutright JL; Sobel JD
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1455-9. PubMed ID: 9210665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
    Najvar LK; Correa A; James P; Luther MF; Graybill JR
    J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
    Fung-Tomc JC; White TC; Minassian B; Huczko E; Bonner DP
    Diagn Microbiol Infect Dis; 1999 Oct; 35(2):163-7. PubMed ID: 10579098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of D0870 against murine infections and its mechanism of action.
    Yamada H; Tsuda T; Watanabe T; Kusakabe S; Mochizuki H
    Chemotherapy; 1998; 44(2):112-20. PubMed ID: 9551242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    Venkateswarlu K; Denning DW; Kelly SL
    J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
    Król J; Nawrot U; Bartoszewicz M
    J Mycol Med; 2018 Jun; 28(2):327-331. PubMed ID: 29605543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.